USE OF B-TYPE NATRIURETIC PEPTIDE AS A PROGNOSTIC INDICATOR IN ACUTE CORONARY SYNDROMES

摘要

The present invention relates to materials and procedures for evaluating theprognosis of patients suffering from acute coronary syndromes. In particular,the level of BNP, or a marker related to BNP, in a patient sample, alone or incombination with one or more other prognostic markers, provides prognosticinformation useful for predicting near-term morbidity and/or mortality acrossthe entire spectrum of acute coronary syndromes, including unstable angina,non-ST-elevation non-Q wave myocardial infarction, ST-elevation non-Q wave MI,and transmural (Q-wave) MI.